Bioequivalence Study of Atazanavir 300 mg Capsule
NCT00393328
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Atazanavir + Ritonavir
DRUG:
Atazanavir + Ritonavir
Sponsor
Bristol-Myers Squibb